Literature DB >> 11357166

Uncoupling of inflammatory and destructive mechanisms in arthritis.

W B van den Berg1.   

Abstract

OBJECTIVE: To update clinicians on recent advances in the differentiation of the mechanisms of inflammation and cartilage destruction in the pathogenesis of rheumatoid arthritis (RA).
METHODS: We present analysis of recent published literature and abstracts that elucidates the independent actions of pivotal proinflammatory cytokines. These experimental data provide the framework for understanding the uncoupling of destructive and inflammatory mechanisms in arthritis.
RESULTS: Tumor necrosis factor-alpha (TNF-alpha) is an important mediator in the inflammation that occurs in RA. Interleukin-1 (IL-1) has a dominant effect on cartilage destruction that occurs later in the disease process. TNF-independent IL-1 production occurs in many RA model situations. Cytokine balance determines the erosive nature of the disease.
CONCLUSION: IL-1 is at least as important as TNF-alpha in promoting the disease process. The pathways by which the inflammatory and destructive changes occur suggest that targeted anticytokine intervention will arrest the cartilage damage that occurs in patients with RA. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357166     DOI: 10.1053/sarh.2001.23704

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  20 in total

1.  Possible use of miRNAs-146a and -499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis.

Authors:  Ghada Ayeldeen; Yasser Nassar; Hanan Ahmed; Olfat Shaker; Tamer Gheita
Journal:  Mol Cell Biochem       Date:  2018-04-26       Impact factor: 3.396

2.  GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice.

Authors:  C Plater-Zyberk; L A B Joosten; M M A Helsen; J Hepp; P A Baeuerle; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2006-10-04       Impact factor: 19.103

Review 3.  Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes.

Authors:  Rana Jahanban-Esfahlan; Saeed Mehrzadi; Russel J Reiter; Khaled Seidi; Maryam Majidinia; Hossein Bannazadeh Baghi; Nasrin Khatami; Bahman Yousefi; Alireza Sadeghpour
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

4.  Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.

Authors:  Kenji Yumoto; Muneaki Ishijima; Susan R Rittling; Kunikazu Tsuji; Yoko Tsuchiya; Shigeyuki Kon; Akira Nifuji; Toshimitsu Uede; David T Denhardt; Masaki Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

5.  Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.

Authors:  Andreas Hess; Roland Axmann; Juergen Rech; Stefanie Finzel; Cornelia Heindl; Silke Kreitz; Marina Sergeeva; Marc Saake; Meritxell Garcia; George Kollias; Rainer H Straub; Olaf Sporns; Arnd Doerfler; Kay Brune; Georg Schett
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

6.  Prognostic laboratory markers of joint damage in rheumatoid arthritis.

Authors:  E Lindqvist; K Eberhardt; K Bendtzen; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

7.  Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.

Authors:  Ruy Carrasco; Judith A Smith; Daniel Lovell
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 8.  Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.

Authors:  Brad Bolon; Marina Stolina; Caroline King; Scot Middleton; Jill Gasser; Debra Zack; Ulrich Feige
Journal:  J Biomed Biotechnol       Date:  2010-12-28

Review 9.  Lessons from animal models of arthritis over the past decade.

Authors:  Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

Review 10.  How does infliximab work in rheumatoid arthritis?

Authors:  Ravinder N Maini; Marc Feldmann
Journal:  Arthritis Res       Date:  2002-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.